Alison Burklund, PhD
Alison Burklund, PhD
Co-Founder and Chief Technology Officer
Nanopath
Dr. Alison Burklund, PhD is Co-Founder and Chief Technology Officer at Nanopath, a growth-stage startup based in Cambridge, MA. Nanopath is working to develop molecular diagnostics for women – a healthcare space that has been consistently overlooked and under innovated. Nanopath aims to capture granular information that reflects the complex female biology within a single office visit. Alison co-founded Nanopath while working to complete her PhD at Dartmouth’s Engineering School. Prior, Alison received her M.Eng. in Bioengineering from UC Berkeley and B.S. in Chemical Engineering from Johns Hopkins University.